Other growth factor receptors involved in bone regeneration (None)

Other growth factor receptors involved in bone regeneration refers to a diverse group of cell surface receptors that mediate signaling for various growth factors essential for skeletal repair, excluding the primary Bone Morphogenetic Protein (BMP) and Transforming Growth Factor-beta (TGF-beta) families [2, 5]. This category primarily includes receptor tyrosine kinases (RTKs) such as Fibroblast Growth Factor Receptors (FGFRs), Platelet-Derived Growth Factor Receptors (PDGFRs), Insulin-like Growth Factor 1 Receptor (IGF1R), and Vascular Endothelial Growth Factor Receptors (VEGFRs) [3, 7]. These receptors are critical for the recruitment, proliferation, and differentiation of mesenchymal stem cells and osteoprogenitors at the site of bone injury [6, 9]. They also facilitate angiogenesis, which is a prerequisite for successful osteogenesis and bone union [7, 10]. Downstream signaling typically involves the MAPK/ERK and PI3K/Akt pathways, which regulate cell survival and the expression of osteogenic genes [5, 8]. Drugs interacting with these receptors include recombinant growth factor ligands used to promote healing, such as Becaplermin (PDGF-BB) and Trafermin (FGF-2) [2, 9]. Additionally, various tyrosine kinase inhibitors used in oncology, like Imatinib or Sunitinib, can interact with these receptors and potentially impact bone metabolism [1, 8]. Therapeutic use of these pathways must be carefully managed to avoid complications such as ectopic bone formation or the stimulation of mitogenic pathways in non-target tissues [4, 5]. Monitoring of bone-specific biomarkers like alkaline phosphatase and osteocalcin is often employed to assess the efficacy of treatments targeting these receptors [4, 7]. Overall, these receptors represent a significant area of research for enhancing bone tissue engineering and treating complex fractures [9, 10].

Other names

Non-BMP growth factor receptorsBone-active receptor tyrosine kinasesAncillary osteogenic growth factor receptors

These receptors function by binding specific extracellular growth factor ligands, leading to receptor dimerization and autophosphorylation of intracellular tyrosine kinase domains [5, 7]. This triggers downstream signaling pathways, including the MAPK/ERK, PI3K/Akt, and PLC-gamma pathways, which collectively promote the migration, proliferation, and osteogenic differentiation of mesenchymal stem cells and osteoblasts [3, 10].